glp-1 kidney outcomes news today receptor agonists and next-generation metabolic hormone therapies in chronic disease glp-1 kidney outcomes news today

In all cases, the images shown in the Figures are representative, and the outcome of the experiments qualitatively apparent ( e.g ., in showing the presence and extent of ectopic Cut expression)

A warning about compounded semaglutide: the FDA does not approve compounded versions of GLP-1s, and the agency has issued specific warnings about safety risks in 2026

R282Q is a variant associated with SPCD, and localises normally to the plasma membrane 53

P., Bain S

It alleviates antibiotic-related gut damage [269], attenuates dextran sodium sulphate-induced colitis in mice by suppressing the immune response and modulating the gut microbiota [252], and provides relief from psoriasis [240]